RNA-binding proteins (RBPs) control the fate of nearly every transcript in a cell. However, no existing approach for studying these posttranscriptional gene regulators combines transcriptomewide throughput and biophysical precision. Here, we describe an assay that accomplishes this. Using commonly available hardware, we built a customizable, open-source platform that leverages the inherent throughput of Illumina technology for direct biophysical measurements. We used the platform to quantitatively measure the binding affinity of the prototypical RBP Vts1 for every transcript in the Saccharomyces cerevisiae genome. The scale and precision of these measurements revealed many previously unknown features of this well-studied RBP. Our transcribed genome array (TGA) assayed both rare and abundant transcripts with equivalent proficiency, revealing hundreds of low-abundance targets missed by previous approaches. These targets regulated diverse biological processes including nutrient sensing and the DNA damage response, and implicated Vts1 in de novo gene "birth." TGA provided single-nucleotide resolution for each binding site and delineated a highly specific sequence and structure motif for Vts1 binding. Changes in transcript levels in vts1Δ cells established the regulatory function of these binding sites. The impact of Vts1 on transcript abundance was largely independent of where it bound within an mRNA, challenging prevailing assumptions about how this RBP drives RNA degradation. TGA thus enables a quantitative description of the relationship between variant RNA structures, affinity, and in vivo phenotype on a transcriptome-wide scale. We anticipate that TGA will provide similarly comprehensive and quantitative insights into the function of virtually any RBP.
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RNA | next-generation sequencing | systems biochemistry | RNA binding proteins | Vts1 R NA-binding proteins (RBPs) constitute 5-10% of the eukaryotic proteome (1-3) and collectively govern the localization, translation, and decay of virtually every transcript (4) (5) (6) . Despite the ubiquity of RBPs and their central importance in gene regulation, decoding the links between RNA primary sequence and its cadre of regulators remains a major unresolved challenge (7) . Current approaches for characterizing RBP function generally involve trade-offs between throughput, comprehensiveness, and quantitative precision. Biophysical measurements can be made with targeted biochemical approaches such as electrophoretic mobility shift assays (EMSAs) or fluorescence polarization (FP) (8, 9) , but these methods can only interrogate known RNA-protein interactions and are inherently lowthroughput. Selection-based approaches [e.g., in vitro selection, high-throughput sequencing of RNA, and sequence-specificity landscapes (SEQRS)/RNA bind-n-seq (RBNS)] achieve higher throughput, but these techniques remove binding sites from their natural sequence context and identify "winners" based on more than simple affinity (10) . Transcriptome-wide methods, which often use cross-linking and immunoprecipitation [e.g., photoactivatable ribonucleoside-enhanced cross-linking and immunoprecipitation (PAR-CLIP), high-throughput sequencing of RNA isolated by cross-linking and immunoprecipitation (HiTS-CLIP), RNA immunoprecipitation (RIP-chip/seq), individual-nucleotide resolution cross-linking and immunoprecipitation (iCLIP), RNA tagging, targets of RNA-binding proteins identified by editing (TRIBE)] (11-16), have yielded many insights. However, they do not generally provide quantitative information about relative affinity and often suffer from additional drawbacks. First, they generally require high-quality, specific antibodies and are thus not scalable to many proteins of interest. Second, binding targets must be appreciably expressed in an individual cell type and condition to be observed. Third, with notable exceptions (e.g., iCLIP), the sequence resolution of these techniques typically precludes nucleotide-level resolution of binding motifs. Finally, differences in cross-linking efficiency and transcript abundance, both of which can vary over many orders of magnitude, are significant sources of bias in transcriptome-wide approaches (17) (18) (19) .
We overcame these biases with an approach that, for rare and abundant substrates alike, combines the genome-wide scale of Significance High-throughput sequencing has transformed modern biology, but its repertoire is currently confined to reading DNA molecules. Here, we report hardware and software adaptations that allow the very methods that enabled the genomic sequencing revolution to be applied to fluorescence-based biochemical assays, on a massive scale. We demonstrate the unique value of this approach by finding previously unknown features of an ancient developmental regulator, Vts1 (Smaug in metazoans), despite its extensive study with previously available techniques. Our work couples transcriptome-wide measurements of binding affinity, sequence, and structural determinants of binding, and phenotypic outcomes to provide a comprehensive portrait of Vts1 function. Our technology is easily extensible to other RNAbinding proteins involved in disease and development, and facilitates diverse applications in systems biochemistry.
cross-linking methods with the quantitative precision of targeted biochemical experiments. We applied our method to characterize the interactions of the conserved RNA binding domain of a sequence-and structure-specific RBP (Vts1 in Saccharomyces cerevisiae; Smaug in metazoans). We chose to study Vts1 because of its biological significance as a key regulator of RNA stability in development (20) and because decades of prior study provided a gold standard against which to benchmark our results (21) (22) (23) (24) (25) (26) (27) .
Results
An Open-Source Platform for Systems Biochemistry. Our approach directly harnessed the throughput of Illumina sequencing, using the MiSeq sequencing flow cell itself as a platform for high-throughput biochemistry. Although the flow cell provides an ideal substrate for massively parallel experiments, current Illumina instruments are not amenable to customization (28, 29) . Previous methods such as RNA on a massively parallel array (RNA-MaP) and high-throughput sequencing-RNA affinity profiling (HiTS-RAP) overcame this issue by operating on the now antiquated Genome Analyzer II. Here, we built our own hardware platform that enables custom biochemical experiments to be performed on modern sequencing chips. We developed a high-throughput imaging station, combining hardware components from an Illumina Genome Analyzer II with optimized optics, fluidics, and temperature control systems (Fig.  1A) . We integrated these hardware components into a fully programmable interface (Fig. S1A) , creating a modular design that provides a blueprint for future applications to interrogate other classes of biophysical interactions. To enable transfer of the technology to other laboratories, we integrated our imaging platform with sequencing flow cells produced by a benchtop sequencer (MiSeq), using cross-correlation methods to identify the physical location of each sequenced cluster with submicron accuracy (Fig. S1 B-F). This exquisite spatial resolution allowed us to link images generated on our imaging station to specific nucleotide sequences obtained on a commercial sequencer, decoupling the instrument used for sequencing from that used to carry out custom biochemistry applications. Our imaging station thus provides an open platform for systems biochemistry that we expect will encourage further methodological development.
We next densely populated a MiSeq flow cell with an S. cerevisiae genomic DNA library. During library construction, we incorporated an Escherichia coli RNA polymerase (RNAP) promoter and RNAP stall sequence. We then transcribed each DNA molecule into a tethered RNA transcript (Fig. 1A, Figs . S2 and S3A (29, 30) , and Materials and Methods). This transcribed genome array (TGA) displays the entire potential RNA sequence space of S. cerevisiae in a highly redundant and unbiased manner; each nucleotide is represented at a mean coverage of >30× in overlapping transcripts of ∼100-300 nt (Fig. 1B and Fig. S3B ). Moreover, the enzymatically transcribed fragments can adopt physiologically relevant folds that are dependent on local sequence context (see below).
A Multitude of Additional Binding Targets. We used this platform and a workflow that spanned just 36 h to make >10 7 measurements of binding for Vts1 across a ∼100-fold concentration gradient ( Fig. 1 C-E). Using these measurements, we identified 325 RNAs that reproducibly bound Vts1 at physiological protein concentrations (∼130 nM) (31) across the many redundant clusters on the TGA. These apparent affinities were comparable to known Vts1 target elements that we doped into our library (0.1%) as a positive control for RNA folding and protein binding. They also were concordant with published bulk solution measurements (21, 22, 27) (Fig. 1F ; see Materials and Methods for further discussion). Using the RNAcontext algorithm (32), we constructed a de novo binding motif from the 325 Vts1 targets. This analysis revealed two conserved features: (i) a robust 11-nt motif and (ii) a strong enrichment for stem loop structure ( Fig. 2A and Fig. S4 A and B) . Our data thus reiterate yet significantly expand the consensus CNGGN 0-3 hairpin loop defined by decades of targeted biochemical studies in a wide range of organisms (20) (21) (22) (Fig. 2A) .
We next explored the specific structural features that drive Vts1's interactions with its target sequences. If Vts1 indeed binds a stem loop structure, as has been hypothesized from studies of individual substrates (33) , nucleotides within the stem should covary in a manner that preserves base pairing. We therefore constructed a normalized covariation matrix spanning the core 0 GCNGG 4 motif and adjacent bases ( Fig. 2B and Fig. S4 C-E). This analysis confirmed our stem loop prediction and, without any prior assumptions about RNA structure, allowed identification of the Vts1 binding motif at single-nucleotide resolution for each of its targets in the transcriptome (see Materials and Methods for further discussion). As a negative control, we transcribed and folded the entire yeast genome in silico (Fig. S5) . The consensus stem loop structure was highly enriched in our binding targets compared with the rest of the transcriptome (Fig. 2C ).
Structural Requirements for Vts1 Binding. Our known Vts1 target controls included three variants of the Smaug recognition element (SRE), a widely used model Vts1 target. We compared these targets to investigate the sequence and structural features that modulate binding. These variants shared identical loop residues but differed in stem composition (SRE1-3 in Fig. 3 A  and B) . Although no stem composition preferences have previously been reported and no direct stem-Vts1 contacts are observable in the available structures (21, 27) , TGA allowed us to observe approximately 10-fold stronger binding under these conditions to one of these variants (SRE3) (Fig. S6) . We hypothesized that the enhanced apparent affinity of SRE3 arose from a G:C base pair at the base of the loop with guanosine on the 5′ side (position G0), a feature not shared by the other two SREs (SRE3 is not predicted to be more stable than SRE1 or SRE2). Among the 325 endogenous binding targets defined by TGA, ∼60% also had a G:C loop closure [ Fig. 3C ; P < 10 −70 by binomial cumulative distribution function (CDF)]. Collectively, these targets bound Vts1 more strongly than those without G:C closures ( Fig. 3C ; P = 5 × 10
) (20) . In contrast, the inverse C:G base pair was represented in only ∼3% of targets (P < 10 −14 by binomial CDF). These bound Vts1 more weakly than average, although many such stem loops in the transcribed genome likely did not bind Vts1 at all. Based on the NMR structure of Vts1 [Protein Data Bank (PDB) ID code 2ESE], this preference may arise from interactions of G0 with a highly conserved lysine residue within Vts1 (Lys467, Fig. S7B ). Indeed, Lys467 mutant proteins exhibit reduced substrate binding (21, 22) . Among all Vts1 targets, our data revealed that among endogenous targets C:G base pairing between loop positions 1 and 4 is preferred (∼87% of targets) and correlates with the strongest apparent affinities (Fig. 3D) . Following position 4, a variable (0-3 nt) uridine-rich bulge had minor discernable effects on apparent affinity; a 1-nt bulge was most common in Vts1 targets (Fig. 3E , Movie S1, and Materials and Methods).
Functional Consequences of Vts1 Binding. Next, we sought to determine whether the Vts1-RNA interactions identified by TGA had functional consequences in vivo, relying on Vts1's role in targeting its substrates for decay (20, 24) . To do so, we performed high-coverage, stranded RNA-sequencing data on both S. cerevisiae wild-type and Vts1 knockout cells (vts1Δ). Because TGA defines binding targets in a purely in vitro context, in the absence of transfactors, posttranscriptional base modifications, and without regard to transcript localization or abundance, one might expect many of our TGA-defined targets to behave differently in the complex environment of a cell. However, we found a robust phenotypic signature for TGA-defined Vts1 targets. As a class, they were more highly expressed in vts1Δ cells than in wild-type cells (Fig. 4C , P = 1.1 × 10 −6 by permutation test). Target transcripts showing more than twofold increase in expression in vts1Δ cells were significantly stronger binders (P = 0.019 by bootstrap test), highlighting the unique quantitative capability of TGA to systemically link biological phenotypes with fundamental biophysical parameters (Fig. 4A) . Conversely, some up-regulated transcripts were not identified as Vts1 targets by TGA. These could in principle be false negatives. However, none of these up-regulated transcripts were predicted by in silico folding to contain a Vts1 binding motif, making it likely that many were perturbed by indirect effects from true Vts1 substrates. As a whole, computationally predicted Vts1 binding sites showed modest overlap with TGA targets (48/296), but sequences that showed no binding in our in vitro TGA assay exhibited no up-regulation in vts1Δ cells (P < 0.0001, Welch's t test; Fig. S7 F and G) .
We also compared the Vts1 substrates identified by TGA to those determined in two independent RNA immunoprecipitation (RIP-chip) studies (21, 23) (Fig. 4B and Fig. S6E ). The two RIP-chip experiments had poor overlap with each other (19.6% or 42 shared substrates among 214 total). RIP-chip targets missed by TGA were often very abundant, poor matches for the identified binding motif (Fig. S5A) , and showed no change in expression between wild-type and vts1Δ cells (Fig. 4 C and D) . Because these targets exhibited no functional repression by Vts1 in vivo, they could represent false positives inherent to immunoprecipitation methods. Targets common to both TGA and RIP-chip exhibited a stronger degree of up-regulation than either method alone, highlighting a potential synergy between complementary methods for studying RBP function (Fig. S7C) .
TGA analysis also identified 145 binding targets that prior studies did not (325 vs. 180) (21, 23, 27) . These targets included many key regulators of metabolism, cell cycle, and DNA repair (e.g., Tor2, Apc1, Polς) and they clustered into distinct functional subnetworks, for example, controlling nutrient sensing and the DNA damage response (Fig. S8A) . Because we identified these binding events in the absence of additional RBPs and other factors inherent to the cellular environment, we examined their functional relevance. Most of these transcripts bound Vts1 strongly and harbored robust consensus motifs. Virtually all were expressed at low levels in standard growth conditions, highlighting a distinct advantage of TGA's equimolar presentation of the entire potential RNA landscape (Fig. 4D and Fig. S7D ). Critically, these targets were expressed at higher levels in vts1Δ cells (Fig. S7E) , providing strong evidence that they were bona fide targets in vivo.
We picked two TGA-specific targets to investigate in greater depth in vivo. TGA identified the RNA encoding the nutrient sensing protein Tor2, but not its paralog Tor1, as a Vts1 target. The Vts1 binding site in TOR2 fell within a region that encodes an identical amino acid sequence in both paralogs. However, several synonymous mutations abolished the Vts1 binding site in TOR1 (Fig. 4E) . Consequently, in vts1Δ cells, there was an increase in TOR2 expression, whereas TOR1 expression was unchanged (Fig. 4F) . Because the TOR2 gene is essential, we used a tor2 decreased abundance by mRNA perturbation (DAmP) partial loss-of-function allele to reduce its expression while maintaining cell viability (34) . Cells harboring the tor2-DaMP allele were sensitive to the antifungal drug fluconazole, whereas those harboring a vts1 deletion (vts1Δ) were resistant. If tor2-DaMP and vts1Δ acted via independent mechanisms, the combined double-mutant vts1Δ tor2-DaMP cells should display an intermediate phenotype. However, we observed a strong epistatic relationship between the two genes: vts1Δ tor2-DaMP cells grew very similarly to tor2-DaMP single mutant cells (Fig. 4G) . In contrast, mutants in vts1 and tor1 exhibited no epistasis (Fig. 4H) . We next extended our analysis to Rev3, the catalytic subunit of DNA Polς, a translesion polymerase responsible for most mutagenesis in eukaryotic cells and an emerging therapeutic target for chemoresistant malignancies (35) . As others have reported, the rev3Δ cells were sensitive to DNA-damaging agents (Fig. 4I ). vts1Δ cells, in contrast, were more resistant than wild-type cells. The double-mutant vts1Δ rev3Δ cells phenocopied the rev3Δ single mutant, demonstrating negative epistasis between the two genes. These robust genetic interactions demonstrate the power of TGA to reveal previously unknown regulatory relationships for even an exceptionally well-studied RBP.
Vts1 and the Birth of New Genes. Nearly one-third of the Vts1 targets we discovered fell in intergenic sequences. We wondered whether any of these sites might represent functional RBP targets. The S. cerevisiae genome encodes over 100,000 transcribed nongenic sequences (protoORFs). Only a small fraction of these sequences are detectably translated, but many are transcribed at low or moderate levels; these "protoORFs" have been hypothesized to provide a fertile evolutionary testing ground for the birth of new genes (36) . Although previous RIPchip experiments were incapable of detecting protoORF targets for various technical reasons, we asked whether TGA could. Indeed, the vast majority of intergenic TGA targets were contained in previously defined protoORFs (73%, P < 10 −19 , Poisson CDF). We observed no binding to other classes of noncoding RNAs, such as tRNAs, small nucleolar RNAs, or rRNA. The few remaining targets fell in sequences that rarely or potentially never exist as RNA within a cell. These sequences may illustrate the possibility for the Vts1 regulatory motif to arise purely through drift, in the absence of any selection on a functional transcript. Vts1 binding sites were even more strongly enriched among longer (>300 nt) protoORFs (P = 0.023, Poisson CDF), which some have argued are more "evolutionarily developed" and are more likely to be translated (36) (Fig. 4L) .
To determine whether Vts1 regulates protoORF targets in living cells, we again examined our high-coverage, stranded RNA-sequencing data from vts1Δ and wild-type cells. Strikingly, Vts1-targeted protoORFs were as strongly regulated by Vts1 as canonical ORFs, which is remarkable given their recent evolutionary origins ( Fig. 4J ; P = 0.036, bootstrap distribution). We obtained similar results for a set of randomly selected protoORFs not detected in our RNA-seq experiment via quantitative RT-PCR (qRT-PCR) (Fig. S8B) . We propose that acquisition of a Vts1 binding site allows a nascent gene to easily acquire a regulated expression profile downstream of the complex developmental pathways that regulate Vts1/Smaug itself. Acquisition and loss of Vts1 binding sites was not confined to nascent genes alone-among paralogs in the yeast genome, we found 40 pairs of paralogs where only one of the two paralogs contains a Vts1 binding site. In all cases, the nonbinding paralog mutated critical elements of the core Vts1 binding motif. We also discovered three pairs of paralogs that contained Vts1 binding sites in entirely different regions of the transcript. Thus, gain and loss of Vts1 binding sites over evolutionary time can provide a route for diversifying gene duplications and rewiring regulatory networks.
Finally, because TGA provides nucleotide-level resolution, we investigated how the location of a Vts1 binding site within a message influences transcript levels. In light of a large body of literature implicating Vts1 binding in transcript deadenylation via recruitment of the CCR4-NOT1 complex to 3′-UTRs (24, 37) , it is striking that only seven 3′-UTR binding sites occur across the entire transcribed genome array. Indeed, Vts1 binding sites were strongly enriched in 5′-UTRs but not in 3′-UTRs (P = 0.0067, P = 0.31, Poisson CDF; Fig. 4L ). The enrichment in 5′-UTRs could point to the importance of Vts1 in the regulation of translation initiation (25) . However, our genome-wide, nucleotide-resolved dataset established that the impact of Vts1 on transcript abundance is largely independent of where it binds within an mRNA (Fig. 4K) . We conclude that Vts1 binding outside of the 3′-UTR may be the predominant mode by which this RBP regulates gene expression.
Discussion
TGA combines the best features of many separate methods for studying RNA-RBP interactions and complements many of their individual weaknesses (Table 1) (10) . Like RIP-and CLIP-seq, it identifies a transcriptome-wide compendium of functional binding (38, 39) . Last, unlike other methods, TGA enables a quantitative description of the relationship between variant RNA structures, affinity, and in vivo phenotype irrespective of transcript abundance. Although TGA is at its core an in vitro measurement between a recombinant protein and a highly redundant array of RNA fragments, our data demonstrate that experimental evaluation of sequence-and structure-specific binding synergistically complements in vivo measurements of RBP occupancy. Our technology establishes a flexible platform for high-throughput biochemistry that can be easily extended to any nucleic acid template (e.g., the human exome), used to study diverse types of biochemical interaction (e.g., RNA-guided nucleases), and adapted to even higher-throughput systems (e.g., HiSeq). Our application of TGA to Vts1 (i) doubled the number of known Vts1 targets, identifying key regulators of cell cycle and the DNA damage response; (ii) provided a marked improvement in the specificity of the protein's binding motif; (iii) generated structural insight into its ability to discriminate among targets; and (iv) suggested that Vts1 may have a role in regulating the transcripts of evolutionarily nascent genes. The breadth of findings stemming from analysis of an already exceptionally well-studied RBP suggests that TGA technology will be similarly enabling for other RBPs and establishes a paradigm for quantitative, ultrahighthroughput biochemistry.
Materials and Methods
Detailed information is provided in SI Materials and Methods. After sequencing, additional chemistry was performed on the MiSeq flow cell to generate RNA in a manner similar to RNA-MaP methodology (29) . A custom microfluidic station was built from repurposed components harvested from an Illumina Genome Analyzer II (GAII) (see Table S1 for parts list). Vts1 recombinant protein was purified from E. coli. Biological validation of TGA hits was performed in S. cerevisiae. Additional tables, example images, and code can be found at https://www. dropbox.com/s/juo3bnow2wdd8zq/Supplemental%20Data.zip?dl=0.
